| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.68 | 0.03 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.64 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.63 | 0.09 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.57 | 0.009 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.54 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.51 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.47 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.36 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.35 | 0.1 |